Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Belgian hospitals stock up on drugs, kits for possible second COVID wave

Published 2020-08-14, 03:54 a/m
Updated 2020-08-14, 04:00 a/m

By Clement Rossignol and Christian Levaux

BRUSSELS (Reuters) - Belgian hospitals are stockpiling drugs and protective kits and putting in place contingency plans amid a continuing spike in new COVID-19 infections that has forced the capital Brussels to make face masks compulsory in public spaces.

With nearly 10,000 deaths linked to the coronavirus so far, Belgium with a population of 11 million has one of the world's highest death rates from COVID-19 per head.

New infections have risen steadily in recent weeks, with Belgium now reporting one of the highest number of cases per inhabitants of any European country and prompting fears of a second wave.

In March and April when the pandemic accelerated, Belgian hospitals struggled with a shortage of equipment and with administrative hurdles.

They have learned their lesson since then, said chief physician Michel Dewever at the Delta Hospital in Brussels, which has 500 doctors and 500 beds and is part of the Chirec Hospital Group.

"We have stocked up on curare, anesthetics and antibiotics that allow us to last for two or three months during any second wave that might arise," he said.

"We have built up a stock of protective equipment for all the staff, whether it be gloves, gowns or masks. We received part of this inventory from the government. We also bought part of it," Dewever said.

The Group has amassed 20,000 masks, 700,000 gloves, 50,000 single use aprons and 5,000 reusable aprons.

Delta Hospital's contingency plan includes making more beds in the intensive care unit available for COVID-19 patients.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.